Skip to main content
Erschienen in: Cellular Oncology 1/2011

01.02.2011 | Original Paper

Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors

verfasst von: Constantin Jotzu, Eckhard Alt, Gabriel Welte, Jie Li, Bryan T. Hennessy, Eswaran Devarajan, Srinivasalu Krishnappa, Severin Pinilla, Lilly Droll, Yao-Hua Song

Erschienen in: Cellular Oncology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Carcinoma-associated fibroblasts (CAF) are considered to contribute to tumor growth, invasion and metastasis. However, the cell type of origin remains unknown. Since human adipose tissue derived stem cells (hASCs) are locally adjacent to breast cancer cells and might directly interact with tumor cells, we investigated whether CAFs may originate from hASCs.

Methods

hASCs cultured under different conditions were quantified for the expression of alpha smooth muscle actin. ELISA was performed using the human TGFβ1, SDF-1α and CCL5 Quantikine Kit. The invasion potential of MDAMB231 cancer cells was evaluated using a Boyden chamber with filter inserts coated with Matrigel in 24-well dishes.

Results

We demonstrated that a significant percentage of hASCs differentiated into a CAF-like myofibroblastic phenotype (e.g. expression of alpha smooth muscle actin and tenascin-C) when exposed to conditioned medium from the human breast cancer lines MDAMB231 and MCF7. The conditioned medium from MDAMB231 and MCF7 contains significant amounts of transforming growth factor-beta 1 (TGFβ1) and the differentiation of hASCs towards CAFs is dependent on TGFβ1 signaling via Smad3 in hASCs. The induction of CAFs can be abolished using a neutralizing antibody to TGFβ1 as well as by pretreatment of the hASCs with SB431542, a TGFβ1 receptor kinase inhibitor. Additionally, we found that these hASC-derived CAF-like cells exhibit functional properties of CAFs, including the ability to promote tumor cell invasion in an in vitro invasion assay, as well as increased expression of stromal-cell derived factor 1 (SDF-1) and CCL5.

Conclusion

Our data suggest that hASCs are a source of CAFs which play an important role in the tumor invasion.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat W.O. De, P. Demetter, M. Mareel, M. Bracke, Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer 123, 2229–2238 (2008)CrossRef W.O. De, P. Demetter, M. Mareel, M. Bracke, Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer 123, 2229–2238 (2008)CrossRef
2.
Zurück zum Zitat L.A. Kunz-Schughart, R. Knuechel, Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression? Histol. Histopathol. 17, 599–621 (2002)PubMed L.A. Kunz-Schughart, R. Knuechel, Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression? Histol. Histopathol. 17, 599–621 (2002)PubMed
3.
Zurück zum Zitat A.P. Sappino, O. Skalli, B. Jackson, W. Schurch, G. Gabbiani, Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer 41, 707–712 (1988)PubMedCrossRef A.P. Sappino, O. Skalli, B. Jackson, W. Schurch, G. Gabbiani, Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer 41, 707–712 (1988)PubMedCrossRef
4.
Zurück zum Zitat A. Orimo, P.B. Gupta, D.C. Sgroi, F. Renzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson, R.A. Weinberg, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005)PubMedCrossRef A. Orimo, P.B. Gupta, D.C. Sgroi, F. Renzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson, R.A. Weinberg, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005)PubMedCrossRef
5.
Zurück zum Zitat A. Muller, B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S.N. Wagner, J.L. Barrera, A. Mohar, E. Verastegui, A. Zlotnik, Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001)PubMedCrossRef A. Muller, B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S.N. Wagner, J.L. Barrera, A. Mohar, E. Verastegui, A. Zlotnik, Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001)PubMedCrossRef
6.
Zurück zum Zitat W.O. De, Q.D. Nguyen, H.L. Van, M. Bracke, E. Bruyneel, C. Gespach, M. Mareel, Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 18, 1016–1018 (2004) W.O. De, Q.D. Nguyen, H.L. Van, M. Bracke, E. Bruyneel, C. Gespach, M. Mareel, Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 18, 1016–1018 (2004)
7.
Zurück zum Zitat T. Tsujino, I. Seshimo, H. Yamamoto, C.Y. Ngan, K. Ezumi, I. Takemasa, M. Ikeda, M. Sekimoto, N. Matsuura, M. Monden, Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin. Cancer Res. 13, 2082–2090 (2007)PubMedCrossRef T. Tsujino, I. Seshimo, H. Yamamoto, C.Y. Ngan, K. Ezumi, I. Takemasa, M. Ikeda, M. Sekimoto, N. Matsuura, M. Monden, Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin. Cancer Res. 13, 2082–2090 (2007)PubMedCrossRef
8.
Zurück zum Zitat C. Yazhou, S. Wenlv, Z. Weidong, W. Licun, Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast. Tumour. Biol. 25, 290–295 (2004)PubMedCrossRef C. Yazhou, S. Wenlv, Z. Weidong, W. Licun, Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast. Tumour. Biol. 25, 290–295 (2004)PubMedCrossRef
9.
Zurück zum Zitat I. Haviv, K. Polyak, W. Qiu, M. Hu, I. Campbell, Origin of carcinoma associated fibroblasts. Cell Cycle 8, 589–595 (2009)PubMedCrossRef I. Haviv, K. Polyak, W. Qiu, M. Hu, I. Campbell, Origin of carcinoma associated fibroblasts. Cell Cycle 8, 589–595 (2009)PubMedCrossRef
10.
Zurück zum Zitat L. Ronnov-Jessen, O.W. Petersen, Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 68, 696–707 (1993)PubMed L. Ronnov-Jessen, O.W. Petersen, Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 68, 696–707 (1993)PubMed
11.
Zurück zum Zitat N.C. Direkze, K. Hodivala-Dilke, R. Jeffery, T. Hunt, R. Poulsom, D. Oukrif, M.R. Alison, N.A. Wright, Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 64, 8492–8495 (2004)PubMedCrossRef N.C. Direkze, K. Hodivala-Dilke, R. Jeffery, T. Hunt, R. Poulsom, D. Oukrif, M.R. Alison, N.A. Wright, Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 64, 8492–8495 (2004)PubMedCrossRef
12.
Zurück zum Zitat G. Ishii, T. Sangai, T. Oda, Y. Aoyagi, T. Hasebe, N. Kanomata, Y. Endoh, C. Okumura, Y. Okuhara, J. Magae, M. Emura, T. Ochiya, A. Ochiai, Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem. Biophys. Res. Commun. 309, 232–240 (2003)PubMedCrossRef G. Ishii, T. Sangai, T. Oda, Y. Aoyagi, T. Hasebe, N. Kanomata, Y. Endoh, C. Okumura, Y. Okuhara, J. Magae, M. Emura, T. Ochiya, A. Ochiai, Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem. Biophys. Res. Commun. 309, 232–240 (2003)PubMedCrossRef
13.
Zurück zum Zitat P.J. Mishra, P.J. Mishra, R. Humeniuk, D.J. Medina, G. Alexe, J.P. Mesirov, S. Ganesan, J.W. Glod, D. Banerjee, Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 68, 4331–4339 (2008)PubMedCrossRef P.J. Mishra, P.J. Mishra, R. Humeniuk, D.J. Medina, G. Alexe, J.P. Mesirov, S. Ganesan, J.W. Glod, D. Banerjee, Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 68, 4331–4339 (2008)PubMedCrossRef
14.
Zurück zum Zitat J.M. Gimble, A.J. Katz, B.A. Bunnell, Adipose-derived stem cells for regenerative medicine. Circ. Res. 100, 1249–1260 (2007)PubMedCrossRef J.M. Gimble, A.J. Katz, B.A. Bunnell, Adipose-derived stem cells for regenerative medicine. Circ. Res. 100, 1249–1260 (2007)PubMedCrossRef
15.
Zurück zum Zitat P.A. Zuk, M. Zhu, H. Mizuno, J. Huang, J.W. Futrell, A.J. Katz, P. Benhaim, H.P. Lorenz, M.H. Hedrick, Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7, 211–228 (2001)PubMedCrossRef P.A. Zuk, M. Zhu, H. Mizuno, J. Huang, J.W. Futrell, A.J. Katz, P. Benhaim, H.P. Lorenz, M.H. Hedrick, Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7, 211–228 (2001)PubMedCrossRef
16.
Zurück zum Zitat S.Pinilla, E. Alt, F.J. Bdul Khalek, C. Jotzu, F. Muehlberg, C. Beckmann, Y.H. Song, Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett. (2009) S.Pinilla, E. Alt, F.J. Bdul Khalek, C. Jotzu, F. Muehlberg, C. Beckmann, Y.H. Song, Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett. (2009)
17.
Zurück zum Zitat X. Bai, J. Ma, Z. Pan, Y.H. Song, S. Freyberg, Y. Yan, D. Vykoukal, E. Alt, Electrophysiological properties of human adipose tissue-derived stem cells. Am. J. Physiol Cell Physiol 293, C1539–C1550 (2007)PubMedCrossRef X. Bai, J. Ma, Z. Pan, Y.H. Song, S. Freyberg, Y. Yan, D. Vykoukal, E. Alt, Electrophysiological properties of human adipose tissue-derived stem cells. Am. J. Physiol Cell Physiol 293, C1539–C1550 (2007)PubMedCrossRef
18.
Zurück zum Zitat X. Bai, S. Sadat, S. Gehmert, E. Alt, Y.H. Song, VEGF receptor Flk-1 plays an important role in c-kit expression in adipose tissue derived stem cells. FEBS Lett. 581, 4681–4684 (2007)PubMedCrossRef X. Bai, S. Sadat, S. Gehmert, E. Alt, Y.H. Song, VEGF receptor Flk-1 plays an important role in c-kit expression in adipose tissue derived stem cells. FEBS Lett. 581, 4681–4684 (2007)PubMedCrossRef
19.
Zurück zum Zitat B. Hu, Z. Wu, S.H. Phan, Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am. J. Respir. Cell Mol. Biol. 29, 397–404 (2003)PubMedCrossRef B. Hu, Z. Wu, S.H. Phan, Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am. J. Respir. Cell Mol. Biol. 29, 397–404 (2003)PubMedCrossRef
21.
Zurück zum Zitat E.L. Spaeth, J.L. Dembinski, A.K. Sasser, K. Watson, A. Klopp, B. Hall, M. Andreeff, F. Marini, Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS. One. 4, e4992 (2009)PubMedCrossRef E.L. Spaeth, J.L. Dembinski, A.K. Sasser, K. Watson, A. Klopp, B. Hall, M. Andreeff, F. Marini, Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS. One. 4, e4992 (2009)PubMedCrossRef
22.
Zurück zum Zitat J.A. Tuxhorn, G.E. Ayala, D.R. Rowley, Reactive stroma in prostate cancer progression. J. Urol. 166, 2472–2483 (2001)PubMedCrossRef J.A. Tuxhorn, G.E. Ayala, D.R. Rowley, Reactive stroma in prostate cancer progression. J. Urol. 166, 2472–2483 (2001)PubMedCrossRef
23.
Zurück zum Zitat B.A. Teicher, Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev. 20, 133–143 (2001)PubMedCrossRef B.A. Teicher, Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev. 20, 133–143 (2001)PubMedCrossRef
24.
Zurück zum Zitat M.M. Webber, N. Trakul, P.S. Thraves, D. Bello-DeOcampo, W.W. Chu, P.D. Storto, T.K. Huard, J.S. Rhim, D.E. Williams, A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. Carcinogenesis 20, 1185–1192 (1999)PubMedCrossRef M.M. Webber, N. Trakul, P.S. Thraves, D. Bello-DeOcampo, W.W. Chu, P.D. Storto, T.K. Huard, J.S. Rhim, D.E. Williams, A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. Carcinogenesis 20, 1185–1192 (1999)PubMedCrossRef
25.
Zurück zum Zitat D. Wang, J.S. Park, J.S. Chu, A. Krakowski, K. Luo, D.J. Chen, S. Li, Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J. Biol. Chem. 279, 43725–43734 (2004)PubMedCrossRef D. Wang, J.S. Park, J.S. Chu, A. Krakowski, K. Luo, D.J. Chen, S. Li, Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J. Biol. Chem. 279, 43725–43734 (2004)PubMedCrossRef
26.
Zurück zum Zitat J.A. Burger, T.J. Kipps, CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107, 1761–1767 (2006)PubMedCrossRef J.A. Burger, T.J. Kipps, CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107, 1761–1767 (2006)PubMedCrossRef
27.
Zurück zum Zitat F.L. Muehlberg, Y.H. Song, A. Krohn, S.P. Pinilla, L.H. Droll, X. Leng, M. Seidensticker, J. Ricke, A.M. Altman, E. Devarajan, W. Liu, R.B. Arlinghaus, E.U. Alt, Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 30, 589–597 (2009)PubMedCrossRef F.L. Muehlberg, Y.H. Song, A. Krohn, S.P. Pinilla, L.H. Droll, X. Leng, M. Seidensticker, J. Ricke, A.M. Altman, E. Devarajan, W. Liu, R.B. Arlinghaus, E.U. Alt, Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 30, 589–597 (2009)PubMedCrossRef
28.
Zurück zum Zitat E.S. Jeon, H.J. Moon, M.J. Lee, H.Y. Song, Y.M. Kim, M. Cho, D.S. Suh, M.S. Yoon, C.L. Chang, J.S. Jung, J.H. Kim, Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells. Stem Cells 26, 789–797 (2008)PubMedCrossRef E.S. Jeon, H.J. Moon, M.J. Lee, H.Y. Song, Y.M. Kim, M. Cho, D.S. Suh, M.S. Yoon, C.L. Chang, J.S. Jung, J.H. Kim, Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells. Stem Cells 26, 789–797 (2008)PubMedCrossRef
29.
Zurück zum Zitat M. Allinen, R. Beroukhim, L. Cai, C. Brennan, J. Lahti-Domenici, H. Huang, D. Porter, M. Hu, L. Chin, A. Richardson, S. Schnitt, W.R. Sellers, K. Polyak, Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17–32 (2004)PubMedCrossRef M. Allinen, R. Beroukhim, L. Cai, C. Brennan, J. Lahti-Domenici, H. Huang, D. Porter, M. Hu, L. Chin, A. Richardson, S. Schnitt, W.R. Sellers, K. Polyak, Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17–32 (2004)PubMedCrossRef
30.
Zurück zum Zitat A. Orimo, R.A. Weinberg, Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5, 1597–1601 (2006)PubMedCrossRef A. Orimo, R.A. Weinberg, Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5, 1597–1601 (2006)PubMedCrossRef
Metadaten
Titel
Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors
verfasst von
Constantin Jotzu
Eckhard Alt
Gabriel Welte
Jie Li
Bryan T. Hennessy
Eswaran Devarajan
Srinivasalu Krishnappa
Severin Pinilla
Lilly Droll
Yao-Hua Song
Publikationsdatum
01.02.2011
Verlag
Springer Netherlands
Erschienen in
Cellular Oncology / Ausgabe 1/2011
Print ISSN: 2211-3428
Elektronische ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-011-0012-1

Weitere Artikel der Ausgabe 1/2011

Cellular Oncology 1/2011 Zur Ausgabe

List of Reviewers

Reviewers 2010

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie